BOOK A DEMO

Sonic Incytes Selected to Pitch at Innovative HealthTech Competition

Sonic Incytes Medical Corp. has been selected as one of three finalists at the ADA’s 2021 Silicon Valley Leaders Forum HealthTech Showcase, taking place November 19, 2021 in San Mateo, California. Sponsored by Wilson Sonsini, this year’s event will focus on how health technology equity is enabling care for people living with vulnerable conditions.

During the forum, Sonic Incytes will present its accessible and affordable liver health assessment solution, VelacurTM, to a panel of judges, and the audience will vote on the most innovative start-up of the day. The Leaders Forum Innovative HealthTech Competition winner will receive US$10,000 in seed funding.

Sonic Incytes is proud to be a part of this event, which features approximately 60 young healthtech companies (medtech and digital health), with VCs, angels and business executives attending the event.

For more information, visit https://www.wsgr.com/en/events/american-diabetes-associations-26th-annual-leaders-forum-healthtech-showcase-and-thought-leader-discussions.html.

Sync up

with Sonic

Be in-the-know on all our latest news!

Subscribe to our e-newsletter.

Julia PinterMarketing Director

Julia Pinter brings over a decade of medical technology marketing experience spanning product commercialization, launch strategy, and sales enablement. Prior to joining Sonic Incytes, she served as Director of Global GI Product Marketing at PENTAX Medical, where she led global downstream marketing for the company’s largest portfolio — driving commercial launches of next-generation endoscopes, imaging systems, and AI platforms across the Americas, Europe, and Asia-Pacific. At Sonic Incytes, Julia leads downstream marketing initiatives to expand awareness and accelerate adoption of Velacur One®, translating its clinical and economic value into programs that support broader adoption of non-invasive liver assessment.